Koninklijke DSM NV (KDSKF.PK)

KDSKF.PK on OTC Markets Group - US Other OTC and Grey Market

55.15USD
3 Mar 2015
Change (% chg)

-- (--)
Prev Close
$55.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
684
52-wk High
$72.14
52-wk Low
$49.50

KDSKF.PK

Chart for KDSKF.PK

About

Koninklijke DSM NV is a Netherlands-based science company, which is active in health, nutrition and materials sectors. It operates within three main business areas, namely Life Sciences, Materials Sciences and Innovation Center. The Life Sciences area comprises such segments, as Nutrition, which serves the food and beverage,... (more)

Overall

Beta: 0.91
Market Cap(Mil.): €8,949.70
Shares Outstanding(Mil.): 181.43
Dividend: 1.10
Yield (%): 3.34

Financials

  KDSKF.PK Industry Sector
P/E (TTM): 79.09 26.25 17.64
EPS (TTM): 0.62 -- --
ROI: 1.54 6.30 14.99
ROE: 1.84 7.21 17.29
Search Stocks

UPDATE 2-DSM expects 2015 uplift despite low vitamin E prices and currency effects

* To combine 3 non-core units ahead of possible strategic actions

11 Feb 2015

DSM promises stronger 2015 despite low vitamin E prices, currency effects

AMSTERDAM, Feb 11 - DSM, a Dutch life sciences, materials and nutrition company, said it expected 2015 earnings to be higher than last year's despite low Vitamin E prices and negative currency effects, after posting fourth-quarter earnings and sales slightly ahead of estimates.

11 Feb 2015

BRIEF-DSM to sell Synres coating resins unit to Standard Investment

* All employees will on closing date transfer to new owner Source text for Eikon: Further company coverage:

17 Dec 2014

UPDATE 2-DSM may sell or spin off weaker performing businesses

AMSTERDAM, Nov 4 - Dutch food and chemicals group DSM said it might sell or spin off lower-performing units, after hitting profit forecasts in the third quarter despite currency headwinds and low demand in its core nutrition business.

04 Nov 2014

DSM profit down on lower volumes, currency effects

AMSTERDAM, Nov 4 - Dutch food and chemicals group DSM NV earned lower profits in the third quarter, in line with expectations, as currency effects and lower volumes hit its key nutrition business, the company said on Tuesday.

04 Nov 2014

Earnings vs. Estimates

Search Stocks